MA38561B1 - Anticorps anti-igf-1r à liaison fcrn abolie et leur utilisation dans le traitement de maladies vasculaires oculaires - Google Patents

Anticorps anti-igf-1r à liaison fcrn abolie et leur utilisation dans le traitement de maladies vasculaires oculaires

Info

Publication number
MA38561B1
MA38561B1 MA38561A MA38561A MA38561B1 MA 38561 B1 MA38561 B1 MA 38561B1 MA 38561 A MA38561 A MA 38561A MA 38561 A MA38561 A MA 38561A MA 38561 B1 MA38561 B1 MA 38561B1
Authority
MA
Morocco
Prior art keywords
antibodies
treatment
fcrn
igf
abbreviated
Prior art date
Application number
MA38561A
Other languages
English (en)
French (fr)
Other versions
MA38561A1 (fr
Inventor
Matthias Rueth
Guido Hartmann
Joerg Thomas Regula
Wolfgang Schaefer
Tilman Schlothauer
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Priority claimed from PCT/EP2014/058418 external-priority patent/WO2014177461A1/en
Publication of MA38561A1 publication Critical patent/MA38561A1/fr
Publication of MA38561B1 publication Critical patent/MA38561B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA38561A 2013-04-29 2014-04-25 Anticorps anti-igf-1r à liaison fcrn abolie et leur utilisation dans le traitement de maladies vasculaires oculaires MA38561B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13165741 2013-04-29
PCT/EP2014/058418 WO2014177461A1 (en) 2013-04-29 2014-04-25 Fcrn-binding abolished anti-igf-1r antibodies and their use in the treatment of vascular eye diseases

Publications (2)

Publication Number Publication Date
MA38561A1 MA38561A1 (fr) 2017-09-29
MA38561B1 true MA38561B1 (fr) 2018-09-28

Family

ID=48190315

Family Applications (1)

Application Number Title Priority Date Filing Date
MA38561A MA38561B1 (fr) 2013-04-29 2014-04-25 Anticorps anti-igf-1r à liaison fcrn abolie et leur utilisation dans le traitement de maladies vasculaires oculaires

Country Status (3)

Country Link
AR (1) AR096092A1 (es)
MA (1) MA38561B1 (es)
MY (1) MY181915A (es)

Also Published As

Publication number Publication date
MA38561A1 (fr) 2017-09-29
AR096092A1 (es) 2015-12-02
MY181915A (en) 2021-01-14

Similar Documents

Publication Publication Date Title
FR23C1010I2 (fr) Anticorps bispecifiques anti-ang-2/anti-vegf et leur utilisation dans le traitement des maladies vasculaires oculaires
FR24C1001I1 (fr) Anticorps anti-pd1 et leur utilisation en tant qu'agents thérapeutiques et de diagnostic
MA44254A (fr) Anticorps bcma et leur utilisation pour traiter le cancer et les troubles immunologiques
EA201690633A1 (ru) Способы и композиции, включающие комбинацию антагониста vegf и анти-ctla-4 антитела
EA201790377A1 (ru) Антитела к глюкагону и их применения
EA201491530A1 (ru) Модуляторы рецепторов эстрогенов и их применение
EA202193044A2 (ru) Способы лечения таупатии
PH12015501656B1 (en) Anti-il-33 antibodies and use thereof
MA40510A (fr) Molécules bispécifiques de liaison à l'antigène activant les lymphocytes t
MA40972B1 (fr) Molécules bispécifiques de liaison à l'antigène activant les lymphocytes t ciblant folr1 et cd3
EA201592214A1 (ru) Модулятор рецептора эстрогена и его применения
BR112016023948A2 (pt) proteínas fc multiméricas
MA43982A (fr) Anticorps anti-tnf, compositions, méthodes et utilisation pour le traitement ou la prévention du diabète de type 1
UA118674C2 (uk) Антитіло до igf-1r з елімінованою здатністю зв'язуватися з fcrn та його застосування для лікування судинних захворювань очей
EA201992712A2 (ru) Трициклические гетероциклы как ингибиторы белков бэт
EA202090031A3 (ru) Человеческие антитела против gfr3 и способы их применения
MA35660B1 (fr) Inhibiteurs de la protéine pak pour le traitement du syndrome de l'x fragile
EA201692109A1 (ru) Варианты антител к фактору d и их применение
BR112012022102A2 (pt) polipeptídeos de ligação a a-beta.
MA43113A (fr) Anticorps anti-htr a1 et méthodes d'utilisation de ceux-ci
MA47205A (fr) Anticorps spécifiques de la protéine tau hyperphosphorylée pour traiter des maladies oculaires
EA201492282A1 (ru) Антагонистические антигенсвязывающие белки к двум рецепторам и их применение
MA47442A (fr) Anticorps anti-tnf, compositions et méthodes pour le traitement de la spondylarthrite ankylosante active
EA201792575A1 (ru) Фармацевтические композиции леветирацетама пролонгированного высвобождения
EA201692402A1 (ru) Лекарственные формы для местного применения и их использование